ArticleInternational journal of cardiology. Cardiovascular risk and prevention2024

Emerging Lp(a)-Lowering therapies: Is muvalaplin a potential breakthrough?

Zeeshan Afzal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.